Kytopen Corp

Kytopen develops a non-viral gene delivery platform called Flowfect that uses continuous fluid flow combined with electric fields to deliver genetic materials such as mRNA, DNA, and CRISPR components to cells for research and manufacturing applications. The company offers two platforms: Flowfect Discover for high-throughput drug discovery and optimization at small volume scales, and Flowfect TX for large-scale cell engineering and manufacturing.